Skip to content

A Clinical and Pharmacokinetic Study of Chinese Herbal Iontophoresis Formula No. 1 for Treating Optic Nerve Atrophy

A Clinical and Pharmacokinetic Study of Chinese Herbal Iontophoresis Formula No. 1 for Treating Optic Nerve Atrophy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026000709
Enrollment
Unknown
Registered
2026-03-24
Start date
2024-04-30
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Optic nerve atrophy

Interventions

Treatment group:Formula 1 iontophoresis + basic acupuncture treatment
Control Group:5% concentration of Solution No.1 iontophoresis plus basic acupuncture therapy

Sponsors

China Academy of Traditional Chinese Medicine Ophthalmology Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Meets the diagnostic criteria for optic atrophy; 2. Able to cooperate with fundus and related visual function examinations; 3. Patients with optic atrophy aged between 16 and 80 years old; 4. Etiological causes: trauma, ischemia, tumor compression leading to optic nerve lesions; 5. Traumatic optic neuropathy and tumor-compression-induced optic neuropathy with a disease course of =1 month, and ischemic optic neuropathy with a disease course of =2 months, all having entered the optic atrophy stage; 6. Volunteers willing to participate and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. History of allergy to topical medications used in the formula; 2. Presence of ocular surface diseases that prevent compliance with iontophoresis treatment plans; 3. Accompanying other ocular conditions such as optic neuritis, glaucoma, etc.; 4. Pregnant or breastfeeding women, individuals with poorly controlled systemic diseases, poor adherence, or severe mental disorders.

Design outcomes

Primary

MeasureTime frame
Best corrected visual acuity;

Secondary

MeasureTime frame
Field of View;Optical Coherence Tomography;

Countries

China

Contacts

Public ContactWang Ying

China Academy of Traditional Chinese Medicine Ophthalmology Hospital

wangyingtcm@163.com135 8151 5068

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Apr 4, 2026